Citations

Showing 10 of 107969 citations.

Holmium laser enucleation ( HoLEP ) and photoselective vaporisation of the prostate ( PVP ) for patients with benign prostatic hyperplasia (
Jaeger, Christopher , Mitchell, Christopher , Mynderse, Lance A. , Krambeck, Amy E. , Jaeger, Christopher D

Mayo Clinic

BJU International | February 20, 2014 | Volume: 115 | Issue: 2 | Pages: 295-299

10.1111/bju.12674 | PMID 24552209 Get It

Objectives To evaluate short‐term outcomes of holmium laser enucleation of the prostate ( HoLEP ) and photoselective vaporisation of the prostate ( PVP ) in patients with benign prostatic hyperplasia (BPH) and chronic urinary retention ( CUR ). Patients and Methods A retrospective chart review was performed of all patients with CUR who underwent HoLEP or PVP at our institution over a 3‐year period. CUR was defined as a persistent post‐void residual urine volume ( PVR ) of >300 mL or refractory urinary retention requiring catheterisation. Results We identified 72 patients with CUR who underwent HoLEP and 31 who underwent PVP . Preoperative parameters including median catheterisation duration (3 vs 5 months, P = 0.71), American Urological Association Symptom Index score ( AUASI ; 18 vs 21, P = 0.24), and PVR (555 vs 473 mL, P = 0.096) were similar between the HoLEP and PVP groups. The HoLEP group had a larger prostate volume (88.5 vs 49 mL, P < 0.001) and higher PSA concentration (4.5 vs 2.4 ng/mL, P = 0.001). At median 6‐month follow‐up, 71 (99%) HoLEP patients and 23 (74%) PVP patients were catheter‐free ( P < 0.001). Of the voiding patients, postoperative AUASI (3 vs 4, P = 0.06), maximum urinary flow rate (23 vs 18 mL/s, P = 0.28) and PVR (56.5 vs 54 mL, P = 1.0) were improved in both groups. Conclusions Both HoLEP and PVP are effective at improving urinary parameters in men with CUR . Despite larger prostate volumes, HoLEP had a 99% successful deobstruction rate, thus rendering patients catheter‐free.
Monitoring M-Proteins in Patients with Multiple Myeloma Using Heavy-Chain Variable Region Clonotypic Peptides and LC–MS/MS
Barnidge, David R. , Tschumper, Renee C. , Theis, Jason D. , Snyder, Melissa R., Jelinek, Diane F., Katzmann, Jerry A., Dispenzieri, Angela , Murray, David , Snyder, Melissa R., Dispenzieri, Angela

Mayo Clinic

Journal of Proteome Research | February 20, 2014 | Volume: 13 | Issue: 4 | Pages: 1905-1910

10.1021/pr5000544 | PMID 24552626 Get It

Linked distal radioulnar joint arthroplasty: an analysis of the APTIS prosthesis
Fox, Tyler J. , Wagner, Eric R. , Berger, Richard A. , Kakar, Sanjeev , Wagner, Eric R

Mayo Clinic

Journal of Hand Surgery (European Volume) | February 19, 2014 | Volume: 39 | Issue: 7 | Pages: 739-744

10.1177/1753193414523189 | PMID 24554688 Get It

Painful radioulnar convergence following resection of the distal ulna can produce substantial disability and prove a challenging surgical problem, particularly in the revision setting. The purpose of this study was to evaluate the outcome of a series of patients with chronic distal radioulnar joint instability or multiple prior procedures treated with linked distal radioulnar joint arthroplasty with the APTIS prosthesis. A series of ten patients were identified with a mean follow up of 4.0 years. At final follow-up nine of ten implants survived free from revision or removal, with patients experiencing good pain relief and functional outcomes, with reasonable overall satisfaction in all seven patients who returned the questionnaires. Despite the medium-term follow-up and small number of patients, our results suggest the linked distal radioulnar joint arthroplasty may be a viable option for treating painful radioulnar convergence following multiple failed procedures at the distal radioulnar joint.
Beefy Red Plaques in the Perianal Region
Mitkov, Mario , Pimentel, Jason D., Bruce, Alison J., Pimentel, Jason, Bruce, Alison

Mayo Clinic

JAMA Dermatology | February 19, 2014 | Volume: 150 | Issue: 4 | Pages: 447

10.1001/jamadermatol.2013.7639 | PMID 24553775 Get It

Techniques for cytologic sampling of pancreatic and bile duct lesions
Brugge, William R. , Klapman, Jason, Ashfaq, Raheela, Shidham, Vinod B. , Chhieng, David C., Kwon, Richard S. , Zarka, Matthew A., Staerkel, Gregg, DeWitt, John M. , Baloch, Zubair

Mayo Clinic

Diagnostic Cytopathology | February 19, 2014 | Volume: 42 | Issue: 4 | Pages: 333-337

10.1002/dc.23096 | PMID 24554498 Get It

The Papanicolaou Society of Cytopathology has developed a set of guidelines for pancreatobiliary cytology including indications for endoscopic ultrasound guided fine‐needle aspiration biopsy, techniques of the endoscopic retrograde cholangiopancreatography, terminology and nomenclature of pancreatobiliary disease, ancillary testing, and postbiopsy management. All documents are based on the expertise of the authors, a review of the literature, discussions of the draft document at several national and international meetings over an 18‐month period and synthesis of online comments of the draft document on the Papanicolaou Society of Cytopathology website [www.papsociety.org]. This document presents the results of these discussions regarding the use of ancillary testing in the cytological diagnosis of biliary and pancreatic lesions. This document summarizes the current state of the art for techniques in acquiring cytology specimens from the biliary tree as well as solid and cystic lesions of the pancreas. Diagn. Cytopathol. 2014;42:333–337. © 2014 Wiley Periodicals, Inc.
Delayed surgical debridement in pediatric open fractures: A systematic review and meta-analysis
Ibrahim, Talal , Riaz, Muhammad , Hegazy, Abdelsalam , Erwin, Patricia J., Tleyjeh, Imad M. , Tleyjeh, Imad M

Mayo Clinic

Journal of Children's Orthopaedics | February 19, 2014 | Volume: 8 | Issue: 2 | Pages: 135-141

10.1007/s11832-014-0567-2 | PMID 24554129 Get It

Purpose Open fractures are considered orthopedic emergencies that are traditionally treated with surgical debridement within 6 h of injury to prevent infection. However, this proclaimed “6-h rule” is arbitrary and not based on rigorous scientific evidence. The aim of our study was to systematically review the literature that compares late (>6 h from the time of injury) to early (<6 h from the time of injury) surgical debridement of pediatric open fractures. Methods We searched several databases from 1946 to 2013 for any observational or experimental studies that evaluated late and early surgical debridement of pediatric open fractures. We performed a meta-analysis using a random effects model to pool odds ratios for a comparison of infection rates between children undergoing late versus early surgical debridement. We also investigated the infection rates in upper- and lower-limb pediatric open fractures. Descriptive, quantitative, and qualitative data were extracted. Results Of the 12 articles identified, three studies (retrospective cohort studies) were eligible for the meta-analysis, encompassing a total of 714 open fractures. The pooled odds ratio (OR = 0.79) for infection between late and early surgical debridement was in favor of late surgical debridement but was not statistically significant (95 % CI 0.32, 1.99; p = 0.38, I 2 = 0 %). No significant difference in infection rate was detected between pediatric open fractures in the upper and lower limbs according to the time threshold in the included studies (OR = 0.72, 95 % CI 0.29, 1.82; p = 0.40, I 2 = 0 %). Conclusions The cumulative evidence does not, at present, indicate an association between late surgical debridement and higher infection rates in pediatric open fractures. However, initial expedient surgical debridement of open fractures in children should always remain the rule. Thus, multi-center randomized controlled trials or prospective cohort studies will be able to answer this question with more certainty and a higher level of evidence. Level of evidence Level III.
Pain-free Surgery or Pain-free Parking: Measuring Patient Satisfaction with Perioperative Care Is Humbling for the Anesthesiologist
Hyder, Joseph A.

Mayo Clinic

Anesthesiology | February 19, 2014 | Volume: 120 | Issue: 3 | Pages: 780-781

10.1097/aln.0000000000000110 | PMID 24534860 Get It

Retinal Microvascular Abnormalities Predict Progression of Brain Microvascular Disease
Hanff, Thomas C. , Sharrett, A. Richey, Shibata, Dean , Mosley, Thomas H. , Knopman, David S. , Klein, Ronald , Gottesman, Rebecca F.

Mayo Clinic

Stroke | February 19, 2014 | Volume: 45 | Issue: 4 | Pages: 1012-1017

10.1161/strokeaha.113.004166 | PMID 24549866 Get It

Background and Purpose— Brain microvascular disease leads to leukoaraiosis and lacunar infarcts and contributes to risk of stroke and cognitive decline. Given a shared pathophysiology, retinal microvascular signs are expected to predict brain microvascular disease progression. We investigated if either leukoaraiosis volume progression measured continuously or combined with incident lacunar infarcts would better demonstrate expected associations with retinal disease than has previously been shown. Methods— Eight hundred thirty participants in the Atherosclerosis Risk in Communities (ARIC) study aged ≥55 years and without previous stroke received an initial brain magnetic resonance imaging, retinal photography, and, 10 years later, a follow up magnetic resonance imaging. We evaluated retinal vascular sign phenotypes as predictors of (1) leukoaraiosis volume increase, and (2) a new score combining leukoaraiosis volume change and incident lacunar infarcts. Hypertension and diabetes mellitus were evaluated as confounders and effect modifiers. Results— Individuals with any retinopathy (3.34 cm 3 ; 95% confidence interval [CI], 0.74–5.96) or with arteriovenous nicking (2.61 cm 3 ; 95% CI, 0.80–4.42) each had greater progression of leukoaraiosis compared with those without these conditions. Any retinopathy (odds ratio [OR], 3.18; 95% CI, 1.71–5.89) or its components—microaneurysms (OR, 3.06; 95% CI, 1.33–7.07) and retinal hemorrhage (OR, 3.02; 95% CI, 1.27–7.20)—as well as arteriovenous nicking (OR, 1.93; 95%, CI 1.24–3.02) and focal arteriolar narrowing (OR, 1.76; 95% CI, 1.19–2.59), were associated with a higher quartile of a novel brain microvascular disease score combining leukoaraiosis progression with incident subclinical lacunes. Conclusions— A novel scoring method revealed associations of retinal signs with leukoaraiosis progression and brain microvascular disease, which have not been shown before.
Event-Free Survival at 24 Months Is a Robust End Point for Disease-Related Outcome in Diffuse Large B-Cell Lymphoma Treated With Immunochemotherapy
Maurer, Matthew J. , Ghesquières, Hervé , Jais, Jean‐Philippe, Haïoun, Corinne , Thompson, Carrie A. , Delarue, Richard, Micallef, Ivana N. , Peyrade, Frédéric, Macon, William R. , Molina, Thierry Jo , Ketterer, Nicolas , Syrbu, Sergei , Fitoussi, Olivier , Kurtin, Paul J. , Allmer, Cristine, Nicolas‐Virelizier, Emmanuelle , Link, Brian K. , Salles, Gilles , Tilly, Hervé , Cerhan, James R. , Jaïs, Jean‐Philippe , Witzig, Thomas E. , Slager, Susan L. , Habermann, Thomas M. , Maurer, Matthew , Cerhan, James R , Link, Brian K , Salles, Gilles A , Syrbu, Sergei

Mayo Clinic

Journal of Clinical Oncology | February 19, 2014 | Volume: 32 | Issue: 10 | Pages: 1066-1073

10.1200/jco.2013.51.5866 | PMID 24550425 Get It

Purpose Studies of diffuse large B-cell lymphoma (DLBCL) are typically evaluated by using a time-to-event approach with relapse, re-treatment, and death commonly used as the events. We evaluated the timing and type of events in newly diagnosed DLBCL and compared patient outcome with reference population data. Patients and Methods Patients with newly diagnosed DLBCL treated with immunochemotherapy were prospectively enrolled onto the University of Iowa/Mayo Clinic Specialized Program of Research Excellence Molecular Epidemiology Resource (MER) and the North Central Cancer Treatment Group NCCTG-N0489 clinical trial from 2002 to 2009. Patient outcomes were evaluated at diagnosis and in the subsets of patients achieving event-free status at 12 months (EFS12) and 24 months (EFS24) from diagnosis. Overall survival was compared with age- and sex-matched population data. Results were replicated in an external validation cohort from the Groupe d'Etude des Lymphomes de l'Adulte (GELA) Lymphome Non Hodgkinien 2003 (LNH2003) program and a registry based in Lyon, France. Results In all, 767 patients with newly diagnosed DLBCL who had a median age of 63 years were enrolled onto the MER and NCCTG studies. At a median follow-up of 60 months (range, 8 to 116 months), 299 patients had an event and 210 patients had died. Patients achieving EFS24 had an overall survival equivalent to that of the age- and sex-matched general population (standardized mortality ratio [SMR], 1.18; P = .25). This result was confirmed in 820 patients from the GELA study and registry in Lyon (SMR, 1.09; P = .71). Simulation studies showed that EFS24 has comparable power to continuous EFS when evaluating clinical trials in DLBCL. Conclusion Patients with DLBCL who achieve EFS24 have a subsequent overall survival equivalent to that of the age- and sex-matched general population. EFS24 will be useful in patient counseling and should be considered as an end point for future studies of newly diagnosed DLBCL.